Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

por Pettengell, R., Schwenkglenks, M., Bosly, A.
Publicado 2008

Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland

por SCHMUTZ, C., MÄUSEZAHL, D., BLESS, P. J., HATZ, C., SCHWENKGLENKS, M., URBINELLO, D.
Publicado 2017

Are weak or negative clinical recommendations associated with higher geographical variation in utilisation than strong or positive recommendations? Cross-sectional study of 24 heal...

por Ulyte, Agne, Wei, Wenjia, Gruebner, Oliver, Bähler, Caroline, Brüngger, Beat, Blozik, Eva, von Wyl, Viktor, Schwenkglenks, M, Dressel, Holger
Publicado 2021

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

por Krzemieniecki, K., Sevelda, P., Erdkamp, F., Smakal, M., Schwenkglenks, M., Puertas, J., Trojan, A., Szabo, Z., Bendall, K., Maenpaa, J.
Publicado 2013